Michael Robertson

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Susan Buchbinder, Devan V. Mehrotra, Ann Duerr et al. · The Lancet · 2008 · 1.7K citations · Full text

Vaccination, Test-of-concept Trial, Treatment And Prevention +11

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

M. Juliana McElrath, Stephen C. De Rosa, Zoe Moodie et al. · The Lancet · 2008 · 697 citations · Full text

Vaccination, Sexual Health, Human Retrovirus +12

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

David Roth, David R. Nelson, Annette Bruchfeld et al. · The Lancet · 2015 · 663 citations · Full text

Hepatic Disorders, Hepatitis C, Viral Hepatitis +10

Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

Stefan Zeuzem, Reem Ghalib, K. Rajender Reddy et al. · Annals of Internal Medicine · 2015 · 514 citations

Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

Glenda Gray, Mary Allen, Zoe Moodie et al. · The Lancet Infectious Diseases · 2011 · 382 citations · Full text

Vaccination, Hvtn 503/Phambili, Human Retrovirus +9